Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 3
2006 32
2007 36
2008 47
2009 41
2010 32
2011 57
2012 57
2013 43
2014 71
2015 73
2016 64
2017 68
2018 64
2019 41
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

640 results
Results by year
Filters applied: . Clear all
Page 1
Aptamers as Therapeutics.
Nimjee SM, White RR, Becker RC, Sullenger BA. Nimjee SM, et al. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:61-79. doi: 10.1146/annurev-pharmtox-010716-104558. Annu Rev Pharmacol Toxicol. 2017. PMID: 28061688 Free PMC article. Review.
Selection of PD1/PD-L1 X-Aptamers.
Wang H, Lam CH, Li X, West DL, Yang X. Wang H, et al. Biochimie. 2018 Feb;145:125-130. doi: 10.1016/j.biochi.2017.09.006. Epub 2017 Sep 11. Biochimie. 2018. PMID: 28912094 Free PMC article.
Aptamers in HIV research diagnosis and therapy.
Bala J, Chinnapaiyan S, Dutta RK, Unwalla H. Bala J, et al. RNA Biol. 2018 Mar 4;15(3):327-337. doi: 10.1080/15476286.2017.1414131. Epub 2018 Feb 12. RNA Biol. 2018. PMID: 29431588 Free PMC article. Review.
The application of aptamer in apoptosis.
Chen Y, Lin JS. Chen Y, et al. Biochimie. 2017 Jan;132:1-8. doi: 10.1016/j.biochi.2016.10.008. Epub 2016 Oct 14. Biochimie. 2017. PMID: 27750037 Review.
Anti-MUC1 aptamer: A potential opportunity for cancer treatment.
Nabavinia MS, Gholoobi A, Charbgoo F, Nabavinia M, Ramezani M, Abnous K. Nabavinia MS, et al. Med Res Rev. 2017 Nov;37(6):1518-1539. doi: 10.1002/med.21462. Epub 2017 Jul 31. Med Res Rev. 2017. PMID: 28759115 Review.
Aptamers targeting cell surface proteins.
Takahashi M. Takahashi M. Biochimie. 2018 Feb;145:63-72. doi: 10.1016/j.biochi.2017.11.019. Epub 2017 Dec 2. Biochimie. 2018. PMID: 29198584 Review.
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.
Liang C, Guo B, Wu H, Shao N, Li D, Liu J, Dang L, Wang C, Li H, Li S, Lau WK, Cao Y, Yang Z, Lu C, He X, Au DW, Pan X, Zhang BT, Lu C, Zhang H, Yue K, Qian A, Shang P, Xu J, Xiao L, Bian Z, Tan W, Liang Z, He F, Zhang L, Lu A, Zhang G. Liang C, et al. Nat Med. 2015 Mar;21(3):288-94. doi: 10.1038/nm.3791. Epub 2015 Feb 9. Nat Med. 2015. PMID: 25665179 Free PMC article.
Aptamers against pathogenic microorganisms.
Davydova A, Vorobjeva M, Pyshnyi D, Altman S, Vlassov V, Venyaminova A. Davydova A, et al. Version 2. Crit Rev Microbiol. 2016 Nov;42(6):847-65. doi: 10.3109/1040841X.2015.1070115. Epub 2015 Aug 10. Crit Rev Microbiol. 2016. PMID: 26258445 Free PMC article. Review.
Pharmacokinetics, pharmacodynamics and safety of aptamers.
Kovacevic KD, Gilbert JC, Jilma B. Kovacevic KD, et al. Adv Drug Deliv Rev. 2018 Sep;134:36-50. doi: 10.1016/j.addr.2018.10.008. Epub 2018 Oct 12. Adv Drug Deliv Rev. 2018. PMID: 30321620 Free article. Review.
640 results
Jump to page
Feedback